Spinocerebellar ataxia type 35 is a rare inherited brain and nerve condition that mainly affects balance, walking, speech, and coordination. It usually begins in adulthood and gets worse slowly over years, so early symptoms of Spinocerebellar ataxia type 35 may start as mild unsteadiness or slurred speech. Not everyone will have the same experience, but many people with Spinocerebellar ataxia type 35 develop tremor, stiff muscles, or trouble with fine hand movements. Spinocerebellar ataxia type 35 is usually lifelong, and treatment focuses on managing symptoms with physical therapy, speech therapy, mobility support, and medicines for specific problems when needed. Life expectancy in Spinocerebellar ataxia type 35 can vary, but severe complications are not inevitable and care often centers on safety, function, and quality of life.
How many people live with Spinocerebellar ataxia type 35?
Spinocerebellar ataxia type 35 is so rare that there is no recent, reliable estimate of how many people are living with it worldwide or in the United States. Rare disease sources such as Orphanet and the U.S. NIH Genetic and Rare Diseases Information Center say its prevalence is unknown and do not provide a dependable global or U.S. count (Orphanet, 2024; GARD, 2024).
Overview
Spinocerebellar ataxia type 35Symptoms
Spinocerebellar ataxia type 35 usually causes worsening balance and coordination problems, often leading to an unsteady walk, slurred speech, and shaky hand movements. Early symptoms of spinocerebellar ataxia type 35 can also include muscle stiffness and abnormal eye movements.
Outlook and prognosis
Spinocerebellar ataxia type 35 usually progresses slowly over years. Many living with SCA35 notice balance, coordination, speech, and swallowing may gradually become harder, while thinking is often less affected. Physical, speech, and swallowing support can help maintain daily function and safety.
Causes and risk factors
Spinocerebellar ataxia type 35 is caused by a harmful TGM6 gene change, usually inherited from one affected parent, though it can be new in a family. Lifestyle and environmental factors do not cause it, but age may affect severity.
Genetic influences
Genetics are central to spinocerebellar ataxia type 35, which is caused by a harmful change in the TGM6 gene. This variant is usually inherited in an autosomal dominant pattern, so a parent with spinocerebellar ataxia type 35 can pass it on.
Diagnosis
Diagnosis of spinocerebellar ataxia type 35 starts with symptoms, family history, and a neurologic exam. Doctors look for clinical features such as balance, walking, speech, and eye movement changes. Genetic tests confirm spinocerebellar ataxia type 35.
Treatment and drugs
Treatment for spinocerebellar ataxia type 35 focuses on easing symptoms and protecting daily function. Many living with spinocerebellar ataxia type 35 benefit from physical and occupational therapy, speech therapy, mobility aids, and medicines for stiffness, tremor, or mood symptoms.
Symptoms
Many people with Spinocerebellar ataxia type 35 notice that balance, coordination, and clear speech become harder in everyday life. The changes often build slowly, so walking on uneven ground, using buttons, or speaking quickly may take more effort than before. Features vary from person to person and can change over time. Because this condition is inherited, some families notice similar problems across generations, while others do not recognize the pattern right away.
One of the early features of Spinocerebellar ataxia type 35 is a wide-based, unsteady walk, especially when turning, walking in the dark, or using stairs. Many people start reaching for walls or handrails because their body does not correct small slips as smoothly.
Movements of the hands and arms can become less accurate, so writing, using keys, or handling utensils may take longer. You may notice overshooting a cup or missing a buttonhole even though your strength feels fairly normal.
Speech can sound slow, slurred, or uneven because the muscles used for talking are not working in perfect coordination. Conversations may take more effort, especially when someone is tired or trying to speak quickly.
Some people develop coughing or a feeling that food or liquids are going down the wrong way. Meals may take longer, and repeated choking episodes should be checked because they can increase the risk of chest infections.
How people usually first notice Spinocerebellar ataxia type 35?
People usually first notice spinocerebellar ataxia type 35 when walking starts to feel less steady than it used to, with unexplained stumbling, trouble turning, or a sense that balance is slowly slipping. The first signs of SCA35 can also include clumsier hand movements, shakier writing, slurred speech, or trouble with tasks that need precise coordination, and these changes often build gradually rather than appearing all at once. Because SCA35 is rare and progresses slowly, many living with it first wonder whether the problem is simple clumsiness, aging, or an inner ear issue before a pattern of worsening coordination leads to medical evaluation.
Types of Spinocerebellar ataxia type 35
No distinct types of Spinocerebellar ataxia type 35 are widely recognized.
Can I slow down the onset of symptoms?
At this time, there is no good evidence that lifestyle changes or medicines can meaningfully delay when symptoms first begin in spinocerebellar ataxia type 35. Research is still limited because this is a very rare inherited condition, but staying as healthy as possible with regular physical activity, good sleep, treatment of problems like high blood pressure or diabetes, and avoiding excess alcohol or other things that affect balance may help overall brain and body health; still, that is not the same as preventing the condition or proving that onset will be delayed. There is no proven preventive drug for SCA35, but early follow-up with a nerve specialist and genetic counselor can help with planning and early symptom care, and while this may not change when the disease starts, it can still make a real difference in day-to-day life.
What genetics can tell you about symptoms
Genetics can give some clues about symptoms in spinocerebellar ataxia type 35, but it cannot predict the full picture for any one person. Changes in the related gene are linked to problems with balance and coordination, and some people also develop speech changes, shaky movements, or stiffness, but the exact mix of symptoms, how severe they become, and the age they start can vary even within the same family. In general, the genetic finding helps confirm the diagnosis and may suggest a pattern of disease, while day-to-day symptoms still need to be understood from the person’s own course over time.
Causes and risk factors
Balance problems in spinocerebellar ataxia type 35 usually trace back to a harmful change in the TGM6 gene. This gene change is often inherited from a parent, but in some families it can start for the first time in one person. A family history of spinocerebellar ataxia type 35 raises the chance of having the same gene change, and each child of an affected parent has a 1 in 2, or 50%, chance of inheriting it. Having a gene change doesn’t mean you’ll definitely develop the condition. Age, other health conditions, and possibly lifestyle or environmental factors may help shape when early symptoms of spinocerebellar ataxia type 35 begin and how quickly they progress, but they are not the main cause.
What are the most common causes or risk factors?
Spinocerebellar ataxia type 35 is mainly caused by a harmful change in a gene called TGM6, and it is most often passed down in families, so having a parent with the condition is the biggest risk factor. Because only one changed copy of the gene is enough to cause it, each child of an affected parent has a 1 in 2 chance of inheriting it. In some people, the gene change appears for the first time without a family history, and there are no known common lifestyle or environmental risk factors.
Environmental and biological risk factors
Spinocerebellar ataxia type 35 is very rare, so the usual list of environmental and body-based risk factors is not well defined. At this time, environmental and other biological risk factors for spinocerebellar ataxia type 35 have not been clearly identified. Researchers are still exploring how outside influences interact with our inner biology.
No established evidence shows that pollutants, heavy metals, radiation, or similar exposures increase the likelihood of spinocerebellar ataxia type 35. Research is limited because so few people have been studied.
Maternal illnesses, infections, medicines, and birth complications have not been confirmed as causes of spinocerebellar ataxia type 35. So far, no pregnancy-related exposure has been shown to clearly raise risk in a consistent way.
Advanced maternal or paternal age has not been established as a risk factor for spinocerebellar ataxia type 35. Current evidence is too limited to show a clear link.
There is no strong evidence that sex, body size, or common medical conditions increase the chance of spinocerebellar ataxia type 35. For many living with rare conditions, this can mean the cause is not tied to the usual body-based risk patterns seen in more common disorders.
Genetic risk factors
For many families, spinocerebellar ataxia type 35 seems to run from one generation to the next. When people ask about the genetic causes of spinocerebellar ataxia type 35, the main known cause is a harmful change in a gene called TGM6. Some risk factors are inherited through our genes. In a smaller number of families, the gene change may happen for the first time in one person.
TGM6 gene: The main genetic cause of spinocerebellar ataxia type 35 is a harmful change in the TGM6 gene. When this gene does not work as it should, nerve cells involved in balance and coordination can gradually become affected.
Dominant inheritance: Spinocerebellar ataxia type 35 is usually passed down in an autosomal dominant pattern. This means one changed copy of the gene from either parent can be enough to cause the condition.
Affected parent: If a parent carries the changed TGM6 gene, each child has a 1 in 2, or 50%, chance of inheriting it. This chance is the same for boys and girls.
New gene change: Sometimes the gene change appears for the first time in someone with no known family history. This is called a new, or de novo, variant and can explain an unexpected diagnosis in a family.
Family pattern variation: The same TGM6 change can affect relatives differently. In some families, one person may have clear movement problems while another has milder or later early symptoms of spinocerebellar ataxia type 35.
Lifestyle risk factors
Spinocerebellar ataxia type 35 is an inherited neurologic condition, so lifestyle habits do not cause it. Still, how lifestyle affects spinocerebellar ataxia type 35 can matter for balance, mobility, swallowing safety, fatigue, and day-to-day independence. The main lifestyle-related issues involve movement, nutrition, alcohol use, sleep, and preventing complications from falls and inactivity.
Regular, guided exercise may help preserve strength, flexibility, and walking ability for longer in people with spinocerebellar ataxia type 35. Balance training and physiotherapy can also reduce deconditioning, which may otherwise worsen instability and fatigue.
Poor safety habits at home or staying active without the right support can increase falls when coordination is impaired. Using mobility aids when needed and removing trip hazards may lower injury risk and help maintain confidence with movement.
Eating too little, losing weight, or having an unbalanced diet can make weakness and fatigue more noticeable in spinocerebellar ataxia type 35. If chewing or swallowing becomes difficult, texture changes and dietitian support may help maintain nutrition and reduce choking risk.
Alcohol can further impair coordination, reaction time, and speech, so it may noticeably worsen ataxia symptoms. Heavy use can also increase fall risk and make rehabilitation efforts less effective.
Risk prevention
Living with a condition that affects balance, speech, and coordination can make prevention feel different than it does for common illnesses. With spinocerebellar ataxia type 35, there is currently no proven way to prevent the disease itself if the gene change is inherited, so prevention mainly means lowering the risk of complications, injuries, and avoidable worsening. Prevention is flexible—it adapts to your life and health background. For many, this means combining regular medical follow-up with daily habits that help protect mobility, swallowing, and overall health.
Ongoing care with a neurologist can help track spinocerebellar ataxia type 35 and catch treatable problems early. If early symptoms of spinocerebellar ataxia type 35 are changing, timely review can help adjust therapy, equipment, or safety plans.
Balance and strength training may help many living with spinocerebellar ataxia type 35 stay steadier and more confident with walking. A therapist can also suggest gait aids or exercises that lower fall risk without overexertion.
Simple changes at home, such as removing trip hazards, improving lighting, and adding handrails, can reduce the chance of falls. Supportive shoes and the right walking aid can make everyday movement safer.
If swallowing becomes difficult, assessment by a speech and swallowing specialist can help lower the risk of choking or food going into the lungs. Texture changes, safer eating habits, and posture strategies can make meals easier and safer.
Can you prevent Spinocerebellar ataxia type 35?
No, spinocerebellar ataxia type 35 usually cannot be prevented because it is caused by a change in a gene that is passed down in families. Healthy habits are still important, but they do not stop the condition from developing if someone has the gene change. If this condition runs in your family, genetic counseling can help you understand your chances and talk through testing and family planning options.
Transmission
Spinocerebellar ataxia type 35 is not infectious, so it does not spread from person to person through touch, coughing, sex, food, or everyday contact. Instead, the genetic transmission of Spinocerebellar ataxia type 35 usually happens within families through a changed gene.
In many families, one parent living with Spinocerebellar ataxia type 35 has a 1 in 2 chance of passing it to each child, because one changed copy of the gene can be enough to cause the condition. Less often, the gene change can appear for the first time in someone with no known family history.
When to test your genes
Consider genetic testing if you or close relatives have unexplained balance problems, unsteady walking, slurred speech, or a diagnosis of cerebellar ataxia, especially when symptoms run in the family. Confirming SCA35 can clarify the cause, guide follow-up, and help relatives understand their own risk.
Diagnosis
Spinocerebellar ataxia type 35 is usually suspected when balance, walking, speech, or hand coordination problems slowly get worse over time. Getting a diagnosis is often a turning point toward answers and support. Doctors look at the pattern of symptoms, the exam findings, and family history, then use imaging and genetic tests to confirm the diagnosis of Spinocerebellar ataxia type 35. Because symptoms can overlap with other causes of ataxia, reaching a clear answer may take more than one visit.
Doctors check balance, walking, eye movements, speech, reflexes, and coordination during a detailed nervous system exam. This helps show whether the cerebellum and connected nerve pathways are likely involved.
The timing and pattern of symptoms matter, including when unsteadiness began and how quickly it has changed. Doctors also ask about tremor, muscle stiffness, swallowing trouble, or cramps, since Spinocerebellar ataxia type 35 can vary from one person to another.
Because this condition is inherited, a detailed family and health history can help reveal a pattern across generations. Even so, a negative family history does not fully rule it out, since relatives may have been undiagnosed or mildly affected.
Magnetic resonance imaging, or MRI, is often used to look for shrinkage of the cerebellum and related brain areas. It cannot prove Spinocerebellar ataxia type 35 by itself, but it can support the diagnosis and help rule out other causes.
How is Spinocerebellar ataxia type 35 diagnosed?
Doctors usually diagnose spinocerebellar ataxia type 35 by looking at the pattern of symptoms, such as slowly worsening balance, walking, speech, and hand coordination problems, and by doing an exam that checks reflexes, eye movements, strength, and coordination, along with asking about family history. A brain scan, usually an MRI, may show that the cerebellum, the part of the brain that helps control movement, has become smaller, and doctors may also do blood tests to rule out other causes of these problems. The diagnosis can then be confirmed with a genetic test that looks for a change in the TGM6 gene.
Stages of Spinocerebellar ataxia type 35
Spinocerebellar ataxia type 35 does not have defined progression stages. This is because symptoms usually worsen gradually over time, but the pace and pattern can vary a lot from one person to another rather than following clear step-by-step phases. Doctors usually start with a conversation about balance problems, speech changes, walking, and other early symptoms of spinocerebellar ataxia type 35, then add a neurologic exam and often brain imaging to look for other causes. Monitoring usually focuses on how movement, coordination, speech, and daily activities are changing over time, and genetic testing is used to confirm the diagnosis.
Outlook and prognosis
The outlook for people with spinocerebellar ataxia type 35 is variable, but it is generally a slowly progressive neurologic disorder that leads to worsening problems with balance, coordination, speech, and sometimes additional movement or cognitive symptoms over time. Many affected individuals remain able to walk for years after symptoms begin, although some eventually need a cane, walker, or wheelchair as disability advances. Life expectancy is not well defined because the condition is rare, but available reports suggest that many people survive for decades after onset, especially when complications are prevented and supportive care is available. Mortality is usually related less to the genetic disorder itself than to secondary problems that can occur in advanced disease, such as falls, aspiration, infections, or complications of reduced mobility. Prognosis often depends on age at onset, symptom severity, rate of progression, and access to rehabilitation, speech and swallowing evaluation, and other multidisciplinary care. Because spinocerebellar ataxia type 35 is uncommon, long-term outcome data remain limited, and an individual neurologist or genetics team can give the most accurate guidance for a specific patient.
Long-term effects
Spinocerebellar ataxia type 35 usually affects day-to-day movement first, often making walking, balance, speech, and hand control harder over time. The long-term picture is often one of gradual progression, although the speed and pattern can differ from one person to another. Many living with spinocerebellar ataxia type 35 stay mentally alert, but physical tasks may take more effort as the condition advances. Some effects may be mild for years, while others can become more limiting with age.
Balance and coordination often worsen over time, so walking may become slower, wider-based, and less steady. Many people with spinocerebellar ataxia type 35 eventually need a cane, walker, or wheelchair for safety and longer distances.
As balance becomes less reliable, falls can become more common, especially on stairs, uneven ground, or in dim light. Even early symptoms of spinocerebellar ataxia type 35 can include subtle stumbling or veering that later becomes more noticeable.
Fine motor tasks such as buttoning clothes, writing, typing, or using utensils may gradually become harder. For many, this can mean daily routines take longer and require more help.
Speech may become slurred or slower, which can make conversations tiring or frustrating. Some people also develop swallowing trouble, raising the risk of coughing during meals, poor nutrition, or chest infections.
How is it to live with Spinocerebellar ataxia type 35?
Living with spinocerebellar ataxia type 35 often means adapting to slowly worsening problems with balance, coordination, and speech, so everyday tasks like walking, writing, eating, or speaking clearly may take more time and effort. Many people with this condition benefit from physical, occupational, and speech therapy, along with home changes such as handrails or mobility aids, which can help preserve independence and safety. For family and friends, the condition can bring practical caregiving demands and emotional strain, but steady support, planning, and rehabilitation can make daily life more manageable and help people with SCA35 stay engaged in work, relationships, and routines for as long as possible.
Treatment and drugs
Spinocerebellar ataxia type 35 is treated mainly by managing symptoms and helping people stay as steady, safe, and independent as possible, since there is no treatment yet that can stop or reverse the condition itself. Treatment often looks different for each person, but it commonly includes physical therapy for balance and walking, occupational therapy for daily tasks like dressing or using utensils, and speech therapy if speaking or swallowing becomes harder. Doctors may also prescribe medicines to ease problems such as muscle stiffness, tremor, dizziness, sleep trouble, or low mood, depending on what symptoms are causing the most day-to-day difficulty. For many living with Spinocerebellar ataxia type 35, this can mean using a cane or walker, doing regular home exercises, and making simple home changes to lower the risk of falls. Supportive care can make a real difference in how you feel day to day, and follow-up with a neurologist is important because treatment may need to change as symptoms change over time.
Can you cure Spinocerebellar ataxia type 35?
No, there is no cure right now for spinocerebellar ataxia type 35. Treatment focuses on managing symptoms and helping people stay as active and independent as possible, often with physical therapy, speech therapy, and support for walking, balance, and daily tasks. Research is ongoing, but there is not yet a proven treatment that can stop or reverse the condition.
Non-drug treatment
Day-to-day life with spinocerebellar ataxia type 35 often centers on balance, walking, speech, and fine hand movements, so non-drug care is a big part of treatment. There is no cure yet, but rehabilitation and practical supports can help many living with spinocerebellar ataxia type 35 stay safer, more independent, and more comfortable. Supportive therapies can be tailored over time as symptoms change. Care is usually guided by a neurologist, with therapists adding tools for movement, communication, swallowing, and daily activities.
Physical therapy focuses on balance, strength, flexibility, and safer walking. For many, treatment begins not at the pharmacy, but with balance exercises for spinocerebellar ataxia type 35 and practice getting up, turning, and moving on uneven ground. A therapist may also suggest a cane, walker, or ankle support to lower fall risk.
Occupational therapy helps with dressing, bathing, cooking, writing, and other daily tasks when coordination is less steady. Some strategies can slip naturally into your routine—like using weighted utensils, grab bars, shower chairs, or small changes in how you set up your home. The goal is to save energy and make everyday activities safer.
Speech therapy can help if words become slurred or harder for others to follow. Exercises may improve clarity, breath support, and pacing, and therapists can teach simple communication strategies for busy or noisy settings. If speech becomes more limited, communication devices or phone-based tools may help.
Some people with spinocerebellar ataxia type 35 develop coughing with meals, food sticking, or trouble managing thin liquids. A speech-language pathologist can check swallowing and suggest safer food textures, drinking strategies, and eating positions. This can help lower the risk of choking and chest infections.
Your genes may have an impact on how drugs work for you
For people living with spinocerebellar ataxia type 35, there is no well-established evidence that the gene change causing the condition clearly predicts how common symptom-relief medicines will work. In day-to-day care, treatment is usually chosen based on the problems someone is having, such as muscle stiffness, shaky movements, sleep trouble, or mood changes, and doctors often adjust medicines slowly because benefit and side effects can vary a lot from one person to another. In other words, for this condition, medicine response is usually guided more by careful follow-up and how someone feels over time than by genetic testing for drug response.
Pharmacological treatments
Day-to-day treatment for Spinocerebellar ataxia type 35 usually focuses on easing symptoms rather than changing the course of the condition itself. There is currently no medicine proven to stop or reverse Spinocerebellar ataxia type 35, but several drugs may help with balance-related symptoms, stiffness, tremor, mood, or other specific problems. Not everyone responds to the same medication in the same way. When people ask about treatment for spinocerebellar ataxia type 35, the best option often depends on which symptoms affect daily life most.
No medication is specifically approved to treat the underlying cause of Spinocerebellar ataxia type 35. In practice, doctors usually choose medicines based on the symptoms that are most disruptive, such as stiffness, tremor, or dizziness.
Riluzole has been studied in some hereditary ataxias and may offer modest help with coordination or walking for some people. It is not a cure for Spinocerebellar ataxia type 35, and blood tests are usually needed to watch for liver side effects.
4-aminopyridine, and the related drug dalfampridine, may be used when people with Spinocerebellar ataxia type 35 have certain eye-movement problems or episodic worsening. These medicines are not right for everyone because they can raise seizure risk in some people.
Baclofen and tizanidine are often used if muscle stiffness, spasms, or spasticity make walking or transfers harder. They can help some people move more comfortably, but sleepiness and weakness can limit how much is tolerated.
Genetic influences
Spinocerebellar ataxia type 35 happens because of a change in the TGM6 gene, so this is a clearly inherited form of ataxia rather than a condition with many unrelated possible causes. It usually follows an autosomal dominant pattern, which means a parent with the gene change can pass it on to each child with a 1 in 2, or 50%, chance. Family history is one of the strongest clues to a genetic influence, but some people are the first in their family known to have spinocerebellar ataxia type 35 because earlier relatives were never diagnosed or had milder symptoms. Many living with spinocerebellar ataxia type 35 may notice that symptoms begin at different ages and can be more or less severe from one family member to another. Genetic testing can confirm the TGM6 change and may help with diagnosis, family planning, and discussions with relatives who may also want testing or genetic counseling.
Is Spinocerebellar ataxia type 35 genetic?
Genetics are central to spinocerebellar ataxia type 35, which is caused by a harmful change in the TGM6 gene. This variant is usually inherited in an autosomal dominant pattern, so a parent with spinocerebellar ataxia type 35 can pass it on.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal part of human biology. Most do not directly affect health and instead are part of natural human diversity. In many genes, carrying a variant associated with a condition suggests a possible link rather than a clear diagnosis, especially when several genes and environmental factors play a part. In some cases, though, a single well-understood variant in a particular gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with Spinocerebellar ataxia type 35, often called SCA35, treatment is usually about easing day-to-day problems with balance, coordination, speech, and independence rather than using one drug that fixes the underlying genetic change. The genetic result matters because it confirms the type of ataxia, which helps doctors plan supportive care, watch for expected symptoms, and avoid mistaking it for a different condition that may need a different approach. Not every difference in response is genetic, but there are no well-established gene-based prescribing rules that are specific to Spinocerebellar ataxia type 35. In other words, how genetics affect treatment for Spinocerebellar ataxia type 35 is mostly about getting the diagnosis right, guiding family counseling, and helping people find the most appropriate care. If medicines are used to ease related symptoms, inherited differences in how the body processes drugs can still affect side effects or benefit, and pharmacogenetic testing may sometimes be considered when medication responses are unusual. In practice, treatment is usually individualized, with physical, occupational, and speech therapy playing a central role while medications are adjusted carefully based on symptoms, other health conditions, and each person’s response.
Interactions with other conditions
For many living with spinocerebellar ataxia type 35, day-to-day problems like unsteady walking, slurred speech, or trouble swallowing can become more disruptive when another health condition is also present. Day-to-day, it can feel like one health issue amplifies the other. For example, arthritis, poor vision, inner ear problems, or nerve damage in the feet can further affect balance and raise the risk of falls, while depression, anxiety, or sleep disorders may make fatigue and coping harder. If swallowing is affected, lung infections such as aspiration pneumonia can become a concern because food or liquid may go down the wrong way more easily. People with spinocerebellar ataxia type 35 may also find that alcohol misuse, vitamin deficiencies, or other brain and nerve disorders blur the picture and make early symptoms of spinocerebellar ataxia type 35 harder to sort out. Because this condition is rare, there is no single, well-established pattern of disease overlap unique to spinocerebellar ataxia type 35, so doctors usually look carefully for other treatable problems that could be adding to symptoms.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Spinocerebellar ataxia type 35?
Other inherited balance disorders, especially other types of spinocerebellar ataxia and Friedreich ataxia, can look a lot like spinocerebellar ataxia type 35 because they also cause slowly worsening trouble with balance, coordination, walking, and speech. Conditions that are not inherited can sometimes cause similar problems too, including multiple system atrophy, multiple sclerosis, stroke, low vitamin B12 or vitamin E levels, heavy alcohol use, and side effects from some medicines. The cause often becomes clearer from the pattern of symptoms over time, family history, a neurologic exam, brain scans, and genetic testing.
History
Long before spinocerebellar ataxia type 35 had its current name, doctors were already describing people with slowly worsening balance problems, clumsiness, and slurred speech that did not fit neatly into the ataxia categories known at the time. In recent decades, awareness has grown as specialists began sorting these overlapping conditions into more precise subtypes, using careful neurological exams, family histories, and later genetic testing to tell them apart.
Spinocerebellar ataxia type 35 was recognized as a distinct form of inherited ataxia in the early 2010s, when researchers connected a characteristic pattern of symptoms with a specific genetic cause. Before that, many living with what we now call spinocerebellar ataxia type 35 may simply have been told they had a hereditary cerebellar disorder or an unspecified spinocerebellar ataxia. That older uncertainty was common because many ataxias can look very similar at first, especially when the main day-to-day problem is gradually worsening walking and coordination.
As more cases were reported, doctors built a clearer picture of spinocerebellar ataxia type 35. They found that symptoms often begin in adulthood and tend to progress slowly, although the exact age symptoms start and the pace of change can differ from one person to another. Some may first notice small changes, such as veering when walking down a hallway, struggling with fine hand movements, or speech becoming less crisp by the end of the day. Those observations helped define the early symptoms of spinocerebellar ataxia type 35 and distinguish it from other neurological conditions that can also affect balance.
The history of spinocerebellar ataxia type 35 also reflects a broader change in medicine. Earlier classifications relied mostly on what doctors could see during an exam, while more recent research has made it possible to link outward symptoms with underlying biological causes. That shift has improved diagnosis and counseling, and it helps explain why some people receive a more specific answer today than they would have a generation ago. Even so, because spinocerebellar ataxia type 35 is rare, knowledge is still growing, and much of what doctors understand now has come from combining careful clinical follow-up with modern laboratory methods.